Antibiotice Iasi pharmaceutical company has signed, together with the Ministry of Investments and European Projects (MIPE), a financing contract worth 75 million euros for the development of a Center for Research-Development and Production of Critical Medicines, through the Health Program - Priority 9 (STEP). According to a press release from the company issued to AGERPRES on Tuesday, the project "Inova a+ Research-Development Center and Critical Medicines Production" will support the Romanian

Tag-uri: Antibiotice Iasi